Citigroup analyst Tyler Radke maintains Iris Energy (NASDAQ:IREN) with a Buy and lowers the price target from $8 to $6.
Accenture Invests In QuantHealth To Accelerate Use Of AI-powered Clinical Trial Simulations To Drive Cost-Effective Drug Development; Terms Of The Investment Were Not Disclosed
Accenture (NYSE:ACN) announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing